Back to Search Start Over

Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1tyrosine kinase inhibitors in chronic myeloid leukemia?

Details

Language :
English
ISSN :
08876924 and 14765551
Issue :
Preprints
Database :
Supplemental Index
Journal :
Leukemia
Publication Type :
Periodical
Accession number :
ejs65889608
Full Text :
https://doi.org/10.1038/s41375-024-02229-3